-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Sell on Ginkgo Bioworks Holdings, Maintains $5 Price Target

Benzinga·09/04/2026 11:01:38
語音播報
BTIG analyst Mark Massaro reiterates Ginkgo Bioworks Holdings (NYSE:DNA) with a Sell and maintains $5 price target.